GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling

Journal of Clinical Investigation

Volumn 117, Issue 6, 2007, Pages 1605-1615

  Ayroldi, Emira ^a   Zollo, Ornella ^a   Bastianelli, Alessandra ^a   Marchetti, Cristina ^a   Agostini, Massimiliano ^a   Di Virgilio, Rosa ^a   Riccardi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GENE SILENCING; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; THYMUS; TUBEROUS SCLEROSIS;

ANIMALS; CELL LINE; CELL PROLIFERATION; DEXAMETHASONE; GLUCOCORTICOIDS; MICE; MICE, INBRED C3H; MUTATION; NIH 3T3 CELLS; RAS PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 34249888804     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30724     Document Type: Article

References (52)

1. Payne, D.N., and Adcock, I.M. 2001. Molecular mechanisms of corticosteroid actions. Paediatr. Respir. Rev. 2:145-150.
2. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. 2000. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J. Neuroimmunol. 109:16-22.
3. Adcock, I.M. 2001. Glucocorticoid-regulated transcription factors. Pulm. Pharmacol. Ther. 14:211-219.
4. Wikstrom, A.C. 2003. Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness. J. Endocrinol. 178:331-337.
5. Almawi, W.Y., Abou Jaoude, M.M., and Li, X.C. 2002. Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects. Hematol. Oncol. 20:17-32.
6. Ausserlechner, M.J., Obexer, P., Bock, G., Geley, S., and Kofler, R. 2004. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death Differ. 11:165-174.
7. Rhee, K., Bresnahan, W., Hirai, A., Hirai, M., and Thompson, E.A. 1995. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res. 55:4188-4195.
8. Clark, A.R., and Lasa, M. 2003. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr. Opin. Pharmacol. 3:404-411.
9. Malumbres, M., and Barbacid, M. 2003. RAS oncogenes: the first 30 years. Nat. Rev. Cancer. 3:459-465.
10. Vojtek, A.B., and Der, C.J. 1998. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273:19925-19928.
11. Katz, M.E., and McCormick, F. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:75-79.
12. Mirza, A.M., et al. 2004. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol. Cell. Biol. 24:10868-10881.
13. Downward, J. 1997. Cell cycle: routine role for Ras. Curr. Biol. 7:R258-R260.
14. Gille, H., and Downward, J. 1999. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274:22033-22040.
15. Kerkhoff, E., and Rapp, U.R. 1998. Cell cycle targets of Ras/Raf signalling. Oncogene. 17:1457-1462.
16. Stacey, D.W. 2003. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 15:158-163.
17. Lavoie, J.N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
18. Muise-Helmericks, R.C., et al. 1998. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273:29864-29872.
19. Morrison, D.K., and Davis, R.J. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19:91-118.
20. Kolch, W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6:827-837.
21. Stewart, S., et al. 1999. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol. Cell. Biol. 19:5523-5534.
22. Kortum, R.L., and Lewis, R.E. 2004. The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol. Cell. Biol. 24:4407-4416.
23. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D., and Therrien, M. 2002. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16:427-438.
24. Wang, H.G., Takayama, S., Rapp, U.R., and Reed, J.C. 1996. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. U. S. A. 93:7063-7068.
25. Li, W., Han, M., and Guan, K.L. 2000. The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev. 14:895-900.
26. Irie, K., et al. 1994. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science. 265:1716-1719.
27. Silverstein, A.M., Grammatikakis, N., Cochran, B.H., Chinkers, M., and Pratt, W.B. 1998. p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J. Biol. Chem. 273:20090-20095.
28. Matheny, S.A., et al. 2004. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature. 427:256-260.
29. Yeung, K., et al. 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 401:173-177.
30. Giehl, K. 2005. Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 386:193-205.
31. Widen, C., Zilliacus, J., Gustafsson, J.A., and Wikstrom, A.C. 2000. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J. Biol. Chem. 275:39296-39301.
32. Kassel, O., et al. 2001. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20:7108-7116.
33. Leis, H., et al. 2004. Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol. Endocrinol. 18:303-311.
34. Takayama, S., Rogatsky, I., Schwarcz, L.E., and Darimont, B.D. 2006. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J. Biol. Chem. 281:17856-17863.
35. Xu, D., Makkinje, A., and Kyriakis, J.M. 2005. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J. Biol. Chem. 280:2924-2933.
36. Hiragun, T., Peng, Z., and Beaven, M.A. 2005. Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells. Mol. Pharmacol. 67:598-603.
37. D'Adamio, F., et al. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity. 7:803-812.
38. Cannarile, L., et al. 2001. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8:201-203.
39. Ayroldi, E., et al. 2002. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell. Biol. 22:7929-7941.
40. Soundararajan, R., Zhang, T.T., Wang, J., Vandewalle, A., and Pearce, D. 2005. A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. J. Biol. Chem. 280:39970-39981.
41. Ayroldi, E., et al. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood. 98:743-753.
42. Franklin, R.A., et al. 1994. Ligation of the T cell receptor complex results in activation of the Ras/ Raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Invest. 93:2134-2140.
43. Cowley, S., Paterson, H., Kemp, P., and Marshall, C.J. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:841-852.
44. Kato-Stankiewicz, J., et al. 2002. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Proc. Natl. Acad. Sci. U. S. A. 99:14398-14403.
45. Li, W., Zhu, T., and Guan, K.L. 2004. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J. Biol. Chem. 279:37398-37406.
46. Roovers, K., and Assoian, R.K. 2000. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays. 22:818-826.
47. Sheng, H., Shao, J., and DuBois, R.N. 2001. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J. Biol. Chem. 276:14498-14504.
48. Webster, J.I., Tonelli, L., and Sternberg, E.M. 2002. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:125-163.
49. Rook, G.A. 1999. Glucocorticoids and immune function. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 13:567-581.
50. Ashwell, J.D., Lu, F.W., and Vacchio, M.S. 2000. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18:309-345.
51. Hibbs, A.R., MacDonal, G., and Garsha, K. 2006. Practical confocal microscopy. In Handbook of biological confocal microscopy. 3rd edition. J.B. Pawley, editor. Springer Science and Business Media LLC. New York, New York, USA. 650-671.
52. Cannarile, L., et al. 2006. Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood. 107:1039-1047.